Division of Cell Therapy Research, U-Medics, Inc., Matsui 8-1, Utano, Uda, Nara, 633-2221, Japan.
Research and Development Center for Regenerative Medicine, Matsui 8-1, Utano, Uda, Nara, 633-2221, Japan.
Hum Cell. 2021 Jul;34(4):1278-1279. doi: 10.1007/s13577-021-00531-1. Epub 2021 Apr 11.
Natural killer T (NKT)-cells with both T- and NK-cell antigens can be classified into αβ or γδ type according to the TCR gene expression. The WHO classification of lymphoid neoplasms did not further subdivide the above-mentioned NKT-cell malignancies according to the expression of these TCR types. γδ T-cells can be stimulated and expanded by Zoledronic acid, usually carrying Vγ9 Vδ2 TCR and various NK-associated receptors (NKR) such as CD56, CD94, CD158a, CD158b, CD161, etc. In contrast, αβ T-type NKT-cells are positive for Vα24 Vβ11 TCR. NKR positive γδ T-cells have clearly different features than the NKT-cells with Vα24 Vβ11 TCR type, αβ NKT. NKT-cells carrying γδ TCR should be classified and named as γδ NKT-cells to distinguish the cells explicitly from αβ NKT-cells.
自然杀伤 T (NKT)-细胞同时具有 T 细胞和 NK 细胞抗原,可以根据 TCR 基因表达分为αβ或γδ型。世界卫生组织(WHO)的淋巴造血系统肿瘤分类并未根据上述 TCR 类型的表达进一步细分上述 NKT 细胞恶性肿瘤。唑来膦酸可以刺激和扩增γδ T 细胞,通常携带 Vγ9 Vδ2 TCR 和各种 NK 相关受体(NKR),如 CD56、CD94、CD158a、CD158b、CD161 等。相比之下,αβ T 型 NKT 细胞则为 Vα24 Vβ11 TCR 阳性。NKR 阳性的 γδ T 细胞与具有 Vα24 Vβ11 TCR 类型的 NKT 细胞(αβ NKT)具有明显不同的特征。携带 γδ TCR 的 NKT 细胞应分类并命名为 γδ NKT 细胞,以将其与 αβ NKT 细胞明确区分开来。